Introduction to next generation of endothelial progenitor cell therapy: A promise in vascular medicine

American Journal of Translational Research

Volumn 7, Issue 3, 2015, Pages 411-421

  Sukmawati, Dewi ^a   Tanaka, Rica ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical application; Endothelial progenitor cell therapy; Ex vivo expansion; Vasculogenesis

Indexed keywords

CD34 ANTIGEN; REACTIVE OXYGEN METABOLITE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR;

BONE MARROW DERIVED MONONUCLEAR CELL; CFU COUNTING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; HUMAN; LIMB ISCHEMIA; NEXT GENERATION SEQUENCING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; TISSUE REGENERATION;

EID: 84929995374     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Asahara T, Murohara T, Sullivan A, Silver M, Zee R, van der Li T, Bernhard Witzenbichler, Gina Schatteman JMI. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis. Science (80) 1997; 275: 964-966.
2. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida a, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore M a, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-7.
3. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-8.
4. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner M, Isner JM. Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vaculogenesis in Physiologycal and Pathological Neovascularization. Circ Res 1999; 85: 221-228.
5. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005; 105: 1068-77.
6. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Cir-culation 2006; 114: 2163-9.
7. Tanaka R, Wada M, Kwon SM, Masuda H, Carr J, Ito R, Miyasaka M, Warren SM, Asahara T, Tepper OM. The effects of flap ischemia on normal and diabetic progenitor cell function. Plast Reconstr Surg 2008; 121: 1929-42.
8. Yang J, Ii M, Kamei N, Alev C, Kwon S-M, Kawamoto A, Akimaru H, Masuda H, Sawa Y, Asahara T. CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow. PLoS One 2011; 6: e20219, 1-14.
9. Lee JH, Lee SH, Yoo SY, Asahara T, Kwon SM. CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Po-tential for Ischemic Diseases. Arterioscler Thromb Vasc Biol 2013; 1622-1634.
10. Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuichi K, Nakashioya C, Yoshiba F, Fukui T, Ito R, Kobori M, Wada M, Asahara T, Miyasaka M. Autologous G-CSF mobilized peripheral blood CD34(+) cell therapy for diabetic patients with chronic non-healing ulcer. Cell Transplant 2014; 23: 167-79.
11. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, Numaguchi Y, Naoe T, Takamatsu J, Komori K, Murohara T. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71: 196-201.
12. Burt RK, Testori A, Oyama Y, Rodriguez HE, Yaung K, Villa M, Bucha JM, Milanetti F, Sheehan J, Rajamannan N, Pearce WH. Auto-logous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010; 45: 111-6.
13. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A. Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
14. Vasa M, Fichtlscherer S, Aicher A., Adler K, Urbich C, Martin H, Zeiher A. M, Dimmeler S. Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease. Circ Res 2001; 89: e1-e7.
15. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw M A, Quyyumi A A, Finkel T, Ph D. Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk. N Engl J Med 2003; 348: 593-600.
16. Tepper Oren M, Robert D. Galiano, Jennifer M. Capla, Christoph Kalka, Paul J. Gagne, Glen R., Jacobowitz JPL and GCG. Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incor-poration Into Vascular Structures. Circulation 2002; 106: 2781-2786.
17. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-7.
18. O E, Lee BH, Ahn HY, Shin JC, Kim HK, Kim M, Park IY, Park YG, Joe YA. Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. FASEB J 2011; 25: 159-69.
19. Janic B, Guo AM, Iskander a SM, Varma NRS, Scicli AG, Arbab AS. Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 2010; 5: e9173, 1-11.
20. Masuda H, Iwasaki H, Kawamoto A, Akimaru H, Ishikawa M, Ii M, Shizuno T, Sato A, Ito R, Horii M, Ishida H, Kato S, Asahara T. Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med 2012; 1: 160-71.
21. Tanaka R, Vaynrub M, Masuda H, Ito R, Kobori M, Miyasaka M, Mizuno H, Warren SM, Asahara T. Quality Control Culture System Restores Diabetic Endothelial Progenitor Cell Vascul-ogenesis and Accelerates Wound Closure. Diabetes 2013; 62: 1-13.
22. Masuda H, Alev C, Akimaru H, Ito R, Shizuno T, Kobori M, Horii M, Ishihara T, Isobe K, Isozaki M, Itoh J, Itoh Y, Okada Y, McIntyre B a S, Kato S, Asahara T. Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 2011; 109: 20-37.
23. Tsukada S, Kwon SM, Matsuda T, Jung SY, Lee J-H, Lee SH, Masuda H, Asahara T. Identification of mouse colony-forming endothelial progenitor cells for postnatal neovascularization: a novel insight highlighted by new mouse colony-forming assay. Stem Cell Res Ther 2013; 4: 20, 1-13.
24. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, Lulli V, Marziali G, Masella B, Müller R, Sgadari C, Testa U, Bonanno G, Peschle C. Identification of the hemangioblast in postnatal life. Blood 2002; 100: 3203-8.
25. Grant MB, May WS, Caballero S, Brown GAJ, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8: 607-612.
26. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder D A, Olson SB, Wong MH, Fleming WH. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004; 103: 13-9.
27. Risau W, Sariola H, Zerwes HG, Sasse J, Ekblom P, Kemler R, Doetschman T. Vascul-ogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 1988; 102: 471-8.
28. Timmermans F, Plum J, Yöder MC, Ingram D A, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med 2009; 13: 87-102.
29. Aicher A, Rentsch M, Sasaki K, Ellwart JW, Fändrich F, Siebert R, Cooke JP, Dimmeler S, Heeschen C. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 2007; 100: 581-9.
30. Ingram D A, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-60.
31. Yoder MC. Defining human endothelial progenitor cells. J Thromb Haemost 2009; 7 Suppl 1: 49-52.
32. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram D A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801-9.
33. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thr-omb Vasc Biol 2004; 24: 288-93.
34. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005; 112: 1618-27.
35. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone Marrow Origin of Endothelial Progenitor Cells and Pathological Neovascu-larization. Circ Res 1999; 85: 221-228.
36. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw M A, Quyyumi A A, Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
37. Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi K, Iwaguro H, Masuda H, Kawamoto A, Asahara T. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 2008; 118: 157-65.
38. Kwon SM, Suzuki T, Kawamoto A, Ii M, Eguchi M, Akimaru H, Wada M, Matsumoto T, Masuda H, Nakagawa Y, Nishimura H, Kawai K, Takaki S, Asahara T. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ Res 2009; 104: 969-77.
39. Kamei N, Kwon SM, Alev C, Ishikawa M, Yokoyama A, Nakanishi K, Yamada K, Horii M, Nishimura H, Takaki S, Kawamoto A, Ii M, Akimaru H, Tanaka N, Nishikawa SI, Ochi M, Asahara T. Lnk deletion reinforces the function of bone marrow progenitors in promoting neovascularization and astrogliosis following spinal cord injury. Stem Cells 2010; 28: 365-75.
40. Hirata K, Li TS, Nishida M, Ito H, Matsuzaki M, Kasaoka S, Hamano K. Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model. Am J Physiol Heart Circ Physiol 2003; 284: H66-70.
41. He T, Smith L, Harrington S, Nath K. Trans-plantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-2384.
42. Awad O, Dedkov EI, Jiao C, Bloomer S, Tomanek RJ, Schatteman GC. Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler Thromb Vasc Biol 2006; 26: 758-64.
43. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571-8.
44. Tongers J, Roncalli JG, Losordo DW. Role of Endothelial Progenitor Cells During ischemia-induced Vasculogenesis and Collateral For-mation. Microvasc Res 2011; 79: 200-206.
45. Kawamoto A, Katayama M, Handa N, Kinoshita M, Takano H, Horii M, Sadamoto K, Yokoyama A, Yamanaka T, Onodera R, Kuroda A, Baba R, Kaneko Y, Tsukie T, Kurimoto Y, Okada Y, Kihara Y, Morioka S, Fukushima M, Asahara T. Intramuscular Transplantation of G-CSF-Mobilized CD34 1 Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single-Blinded, Dose-Escalation Clinical Trial. Stem Cells 2009; 27: 2857-2864.
46. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Tera-mukai S, Fukushima M, Matsubara H. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transpla-ntation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008; 156: 1010-8.
47. Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuchi K, Nakashioya C, Yoshiba F, Fukui T, Ito R, Kobori M, Wada M. Autologous G-CSF-Mobilized Peripheral Blood CD34+ Cell Therapy for Diabetic Patients With Chronic Nonhealing Ulcer. Cell Transplant 2014; 23: 167-179.
48. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006; 113: 1311-25.
49. Fadini G, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012; 110: 624-37.
50. Tepper OM, Carr J, Allen RJ, Chang CC, Lin CD, Tanaka R, Gupta SM, Levine JP, Saadeh PB, Warren SM. Decreased Circulating Progenitor Cell Number and Failed Mechanisms of Stromal Cell-Derived Factor-1α Mediated Bone Marrow Mobilization Impair Diabetic Tissue Repair. Diabetes 2010; 59: 1974-1983.
51. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441-8.
52. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-7.
53. Jarajapu YPR, Caballero S, Verma A, Nakagawa T, Lo MC, Li Q, Grant MB. Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci 2011; 52: 5093-104.
54. Caballero S, Sengupta N, Afzal A, Chang KH, Li Calzi S, Guberski DL, Kern TS, Grant MB. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007; 56: 960-7.
55. Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 2010; 122: 517-26.
56. Piacibello W, Sanavio F, Severino A, Danè A, Gammaitoni L, Fagioli F, Perissinotto E, Cav-alloni G, Kollet O, Lapidot T, Aglietta M. Eng-raftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999; 93: 3736-49.
57. Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells. Exp Hematol 2000; 28: 1470-80.
58. Ott I, Keller U, Knoedler M, Götze KS, Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M, Schömig A, Peschel C, Oostendorp R a J. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 2005; 19: 992-4.
59. Lippross S, Loibl M, Hoppe S, Meury T, Benneker L, Alini M, Verrier S. Platelet released growth factors boost expansion of bone marrow derived CD34(+) and CD133(+) endothelial progenitor cells for autologous grafting. Platelets 2011; 22: 422-32.
60. Schlechta B, Wiedemann D, Kittinger C, Jandrositz A, Bonaros NE, Huber JC, Preisegger KH, Kocher AA. Ex-Vivo Expanded Umbilical Cord Blood Stem Cells Retain Capacity for Myocardial Regeneration. Circ J 2010; 74: 188-194.
61. Senegaglia AC, Barboza L A, Dallagiovanna B, Aita C A M, Hansen P, Rebelatto CLK, Aguiar AM, Miyague NI, Shigunov P, Barchiki F, Correa A, Olandoski M, Krieger M A, Brofman PRS. Are purified or expanded cord blood-derived CD-133+ cells better at improving cardiac function? Exp Biol Med 2010; 235: 119-29.